Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
about
Intrathecal baclofen for treating spasticity in children with cerebral palsyIntrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical originThe incidence and management of tolerance in intrathecal baclofen therapy.Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.Neurosurgical treatment of spasticity and other pediatric movement disorders.Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal originThe need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database.Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.Influence of baclofen on laryngeal and spinal motor drive during cough in the anesthetized catIntrathecal baclofen therapy for spasticity: A compliance-based study to indicate effectiveness.Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.An algorithmic approach to the management of unrecognized hydrocephalus in pediatric candidates for intrathecal baclofen pump implantation.Imaging evaluation of intrathecal baclofen pump-catheter systems.Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications.Intrathecal baclofen therapy in children with acquired brain injuries after drowning: A case series.Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome.Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.Best Practices for Intrathecal Baclofen Therapy: Screening Test.Can Cerebrospinal Fluid Pressure Detect Catheter Complications in Patients Who Experience Loss of Effectiveness With Intrathecal Baclofen Therapy?Selective dorsal rhizotomy for spastic diplegia secondary to stroke in an adult patient.Dexmedetomidine for acute baclofen withdrawal.Neurologic uses of botulinum neurotoxin type A.Adductor release and chemodenervation in children with cerebral palsy: a pilot study in 16 children.Cautious Use of Intrathecal Baclofen in Walking Spastic Patients: Results on Long-term Follow-up.Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.Cost impact of intrathecal polyanalgesia.Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.Paralytic ileus: a complication after intrathecal baclofen therapy.Paradoxical worsening of spasticity and pain in the lower extremities after increasing the dose of intrathecal baclofen--case report.Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy.
P2860
Q24187762-1AF52018-2134-4B04-B681-CD04A1091F53Q33784035-5F38FA66-905F-4AC3-8FF2-3A08EF289A41Q34971740-B4593182-4F14-4258-8DD5-8330658546E5Q35013253-ECFADF46-E52E-4D2C-BFC4-D74C98E114B7Q35292349-B7080426-0417-4459-BB8B-ED733D3D1624Q35477608-646D175D-F27B-4141-BFC6-926C7FF41425Q35803252-39A9B944-3AFE-4A6C-BCE6-F27EA0291E6CQ36507680-59905DB1-2058-488A-8A9A-ADF88FBA98E2Q36869107-EB4DE091-6036-406A-8397-A9E79D15FC27Q37074807-98EBC19A-420A-4838-BD55-7934F63F774EQ37170208-E64F9E28-7612-45CC-8899-1010FFC240A0Q37409633-05433FE0-138F-48BD-8095-4B83554AC499Q37576306-871F3E01-6415-4415-9A79-7FA8C50BA6E7Q37804612-16C4D6AA-6B7B-4D7E-8F6A-C0F03C10E25FQ38131529-C523F8BC-8A23-447E-9377-CCDDCDE41CFCQ38255212-459A2619-D705-49C5-A44B-4219A44F5D9EQ38270466-8CD94C96-EFCD-45A6-B960-0E0DA561E8E5Q38902101-C0829A57-B8D2-4FC0-8F28-32F32E3833F2Q38902123-FF0DF55B-37B6-4B04-9991-714F25D23AD8Q39539927-47C78AE1-641A-44BD-9A94-DCAEB551D3BCQ41111814-031A004A-42E3-4266-AA7C-863A71335BA7Q41658188-8AC92EEC-0E86-4C2B-8D3C-C0D23A24940FQ42086848-30982199-B09D-4DD5-91B4-0884579A457FQ42092064-F55D1B26-3BBB-4638-B885-353EDB1C7FE0Q42723047-C0DB88A0-63FA-4BEA-B2EC-98248F02CE12Q43265525-76D7A676-8150-4751-8923-9D01F0853248Q43763677-E52613D6-B964-424B-8D71-4E9DA21953BAQ46116604-39F7FF41-8AE1-4434-9304-C30EC0A3568DQ48232115-A348AC61-C723-4696-BC5B-8C64164CB926Q48793621-E3A3864F-7881-405A-982C-0357798EDFE2Q50870856-5FF67B20-097C-4069-9A19-155676D21072Q50900908-498CBAB6-C5C1-4731-A7DB-4BC7C5DAABE1
P2860
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@en
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@nl
type
label
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@en
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@nl
prefLabel
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@en
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@nl
P2093
P1476
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
@en
P2093
A Leland Albright
Cindy B Ivanhoe
Dale Swift
John F McLaughlin
Linda E Krach
Richard Gilmartin
P304
P356
10.3171/JNS.2003.98.2.0291
P407
P577
2003-02-01T00:00:00Z